Pharmaids Pharmaceuticals Ltd.
Snapshot View

15.90 -0.80 ▼-4.8%

27 July 2021, 11:24:00 A.M.
Volume: 683

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.pharmaids.com
Financial Indicators
Market Cap 17.22 Cr.
Earnings per share (EPS) 0.10 Trailing Twelve Months Ending 2021-06
Price-Earning Ratio (PE) 168.82 Trailing Twelve Months Ending 2021-06
Industry PE 117.90 Trailing Twelve Months Ending 2021-06
Book Value / Share 8.32 Trailing Twelve Months Ending 2021-06
Price to Book Value 2.01 Calculated using Price: 16.70
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.03 Cr. 10,311,234 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-4.79%
1 Week
-9.66%
1 Month
-10.67%
3 Month
-1.30%
6 Month
+34.18%
1 Year
+238.30%
2 Year
+221.86%
5 Year
+536.00%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 1.76 2.38 -17.79 -3.71 -26.21 7.99 -31.24 -3.76 0.40
Return on Capital Employed (%) 2.12 1.75 -14.96 -4.99 -21.19 7.61 -29.73 -3.02 -4.45
Return on Assets (%) 1.13 1.63 -11.66 -2.42 -16.50 5.08 -23.27 -3.56 0.40

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 2 2 2 2 1 1 1 8 8
Non Curr. Liab. 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 1 1 1 1 1 0 0 0
Minority Int.
Equity & Liab. 3 3 3 3 2 2 1 9 8
Non Curr. Assets 1 1 1 1 1 0 1 4 7
Curr. Assets 2 2 2 2 2 2 1 4 1
Misc. Exp. not W/O
Total Assets 3 3 3 3 2 2 1 9 8

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 1 1 1 2 2 1 0 1
Other Income 0 0 0 0 0 0 0
Total Income 1 1 2 2 2 1 0 1
Total Expenditure -1 -1 -2 -2 -2 -2 -1 -1 0
PBIDT 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items 1
PAT 0 0 0 0 0 0 0 0 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0 -1
Cash Fr. Inv. 0 0 0 0 1
Cash Fr. Finan. -1 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 1 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 6.62 6.62 2.19 2.19 2.19 65.90 65.84 65.81 65.80
Public 93.38 93.38 97.81 97.81 97.81 34.10 34.16 34.19 34.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Fri, 23 Jul 2021
Outcome Of Board Meeting - 23.07.2021
Dear Sir
Please find the attached outcome of the Board Meeting along with the financial results of the Quarter ended 30.06.2021 and Limited Review Report.

Thanks
For Pharmaids Pharmaceuticals Limited
S Padmaja Kalyani
Director
Fri, 16 Jul 2021
Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompayPHARMAIDS PHARMACEUTICALS LTD.
2CINL52520TG1989PLC009679
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: ANNIE JODHANI
Designation: COMPANY SECRETARY COMPLIANCE OFFICER
EmailId: anniejodhani@gmail.com
Name of the Chief Financial Officer: CHILAM SRIKANTH
Designation: CFO
EmailId: pharmaids125@gmail.com

Date: 16/07/2021

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Fri, 16 Jul 2021
Board Meeting Intimation for Board Meeting Intimation
PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2021 inter alia to consider and approve Dear Sir/Madam

Please find attached intimation for the Board Meeting scheduled on 23-07-2021 to consider the unaudited financial results for the quarter ended 30-06-2021 and other matters.

Regards
For Pharmaids Pharmaceuticals Limited.

S. Padmaja Kalyani
Director

Technical Scans View Details

Mon, 26 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Strongly Underperforming Benchmark index Strongly Underperforming Benchmark index
Decreasing Relative Strength - Benchmark index Decreasing Relative Strength - Benchmark index
Strongly Underperforming Sectoral index Strongly Underperforming Sectoral index

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 154,391.34 1,400.50 -0.2%
Adani Transmission Ltd. 102,832.24 912.00 -2.8%
Sundram Fasteners Ltd. 15,507.47 759.55 +2.4%
Redington (India) Ltd. 12,533.66 318.20 -0.8%
MMTC Ltd. 7,140.00 49.90 +4.8%
Novartis India Ltd. 2,432.04 985.90 -0.1%
MSTC Ltd. 2,076.10 294.60 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 167.34 1,400.50 -0.2%
Adani Transmission Ltd. Consolidated 2021-03 84.01 912.00 -2.8%
Sundram Fasteners Ltd. Consolidated 2021-03 43.17 759.55 +2.4%
Redington (India) Ltd. Consolidated 2021-03 16.57 318.20 -0.8%
MMTC Ltd. Standalone 2020-12 0.00 49.90 +4.8%
Novartis India Ltd. Standalone 2021-03 116.37 985.90 -0.1%
MSTC Ltd. Consolidated 2021-03 18.38 294.60 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 9.00 1,400.50 -0.2%
Adani Transmission Ltd. Consolidated 2021-03 16.89 912.00 -2.8%
Sundram Fasteners Ltd. Consolidated 2021-03 6.61 759.55 +2.4%
Redington (India) Ltd. Consolidated 2021-03 2.54 318.20 -0.8%
MMTC Ltd. Standalone 2020-12 7.07 49.90 +4.8%
Novartis India Ltd. Standalone 2021-03 3.42 985.90 -0.1%
MSTC Ltd. Consolidated 2021-03 3.72 294.60 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 1,400.50 -0.2%
Adani Transmission Ltd. Consolidated 2021-03 4.89 912.00 -2.8%
Sundram Fasteners Ltd. Consolidated 2021-03 0.29 759.55 +2.4%
Redington (India) Ltd. Consolidated 2021-03 0.09 318.20 -0.8%
MMTC Ltd. Standalone 2020-03 4.23 49.90 +4.8%
Novartis India Ltd. Standalone 2020-03 0.00 985.90 -0.1%
MSTC Ltd. Consolidated 2020-03 0.55 294.60 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 1,400.50 -0.2%
Adani Transmission Ltd. Consolidated 2021-03 22.81 912.00 -2.8%
Sundram Fasteners Ltd. Consolidated 2021-03 16.70 759.55 +2.4%
Redington (India) Ltd. Consolidated 2021-03 17.02 318.20 -0.8%
MMTC Ltd. Standalone 2020-03 -20.23 49.90 +4.8%
Novartis India Ltd. Standalone 2020-03 1.36 985.90 -0.1%
MSTC Ltd. Consolidated 2020-03 23.14 294.60 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 7.88 1,400.50 -0.2%
Adani Transmission Ltd. Consolidated 2021-03 10.89 912.00 -2.8%
Sundram Fasteners Ltd. Consolidated 2021-03 17.31 759.55 +2.4%
Redington (India) Ltd. Consolidated 2021-03 21.81 318.20 -0.8%
MMTC Ltd. Standalone 2020-03 -2.16 49.90 +4.8%
Novartis India Ltd. Standalone 2020-03 4.73 985.90 -0.1%
MSTC Ltd. Consolidated 2020-03 22.93 294.60 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 1,400.50 -0.2%
Adani Transmission Ltd. Consolidated 2021-03 9,926.33 912.00 -2.8%
Sundram Fasteners Ltd. Consolidated 2021-03 3,644.29 759.55 +2.4%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 318.20 -0.8%
MMTC Ltd. Standalone 2020-03 26,304.71 49.90 +4.8%
Novartis India Ltd. Standalone 2020-03 438.25 985.90 -0.1%
MSTC Ltd. Consolidated 2020-03 1,231.40 294.60 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 1,400.50 -0.2%
Adani Transmission Ltd. Consolidated 2021-03 1,289.57 912.00 -2.8%
Sundram Fasteners Ltd. Consolidated 2021-03 362.71 759.55 +2.4%
Redington (India) Ltd. Consolidated 2021-03 786.61 318.20 -0.8%
MMTC Ltd. Standalone 2020-03 -220.48 49.90 +4.8%
Novartis India Ltd. Standalone 2020-03 10.08 985.90 -0.1%
MSTC Ltd. Consolidated 2020-03 99.71 294.60 -0.1%